Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice

Journal of Comparative Neurology

Volumn 416, Issue 1, 1999, Pages 112-125

  Nimchinsky, Esther A ^a,c   Young, Warren G ^b   Yeung, Glendy ^a   Shah, Ravi A ^a   Gordon, Jon W ^a   Bloom, Floyd E ^b   Morrison, John H ^a   Hof, Patrick R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c WM Keck Structural Biology Laboratory   (United States)

Author keywords

Amyotrophic lateral sclerosis; Brainstem motor nuclei; Motoneuron; Neurodegenerative disease; Quantitative neuroanatomy; Stereology; Transgenic models

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; DISEASE PREDISPOSITION; FACIAL NERVE; GENE MUTATION; HYPOGLOSSAL NERVE; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OCULOMOTOR NERVE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; FACIAL NERVE; FEMALE; HUMANS; HYPOGLOSSAL NERVE; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; NEURONS; OCULOMOTOR NERVE; POINT MUTATION; REFERENCE VALUES; SUPEROXIDE DISMUTASE;

EID: 0033518387     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(20000103)416:1<112::AID-CNE9>3.0.CO;2-K     Document Type: Article

References (79)

1. Abe K, Pan LH, Watanabe M, Kato T, Itoyama Y. 1995. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett 199:152-154.
2. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. 1994. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36:846-858.
3. Andressen C, Blümcke I, Celio MR. 1993. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271:181-208.
4. Annis CM, Vaughn JE. 1998. Differential vulnerability of autonomic and somatic motor neurons to N-methyl-D-aspartate-induced excitotoxicity. Neuroscience 83:239-249.
5. Barnard JW. 1960. The hypoglossal complex of vertebrates. J Comp Neurol 72:489-524.
6. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. 1997. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42:646-654.
7. Bloom FE, Young WG, Nimchinsky EA, Hof PR, Morrison JH. 1997. Neuronal vulnerability and informatics in human disease. In: Koslow SH, Huerta MF, editors. Neuroinformatics - an overview of the human brain project. Mahwah, NJ: Lawrence Erlbaum. p 83-123.
8. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH, Price DL, Sisodia SS, Cleveland DW. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292-8296.
9. Brodal A. 1981. Neurological anatomy in relation to clinical medicine. 3rd ed. New York: Oxford University Press.
10. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price DL, Cleveland DW. 1997a. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 94:7606-7611.
11. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW. 1997b. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338.
12. Bruijn LI, Housewaert MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wid-type SOD1. Science 281:1851-1854.
13. Celio MR. 1990. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35:375-475.
14. Chard PS, Bleakman D, Christakos S, Fullmer CS, Miller RJ. 1993. Calcium buffering properties of calbindin D-28k and parvalbumin in rat sensory neurones. J Physiol 472:341-357.
15. Cleveland DW, Bruijn LI, Wong PC, Marszalek JR, Vechio JD, Lee MK, Xu XS, Borchely DR, Sisodia SS, Price DL. 1996. Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease. Ann Neurol 47(Suppl 2):S54-S62.
16. Dal Canto MC, Gurney ME. 1994. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145:1271-1279.
17. Dal Canto MC, Gurney ME. 1995. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676:25-40.
18. Dal Canto MC, Gurney ME. 1997. A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol 93:537-550.
19. DePaul R, Abbs JH, Caligiuri M, Gracco VL, Brooks BR. 1988. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38:281-283.
20. Elliott JL, Snider WD. 1995. Parvalbumin is a marker of ALS-resistant motor neurons. NeuroReport 6:449-452.
21. Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF. 1997. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 42:326-334.
22. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
23. Fujii J, Myint T, Seo HG, Kayanoki Y, Ikeda Y, Taniguchi N. 1995. Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells. J Neurochem 64:1456-1461.
24. Gizzi M, DiRocco A, Sivak M, Cohen B. 1992. Ocular motor function in motor neuron disease. Neurology 42:1037-1046.
25. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775.
26. Harvey DG, Torack RM, Rosenbaum HE. 1979. Amyotrophic lateral sclerosis with ophthalmoplegia. Arch Neurol 36:615-617.
27. Hirano A. 1991. Cytopathology of amyotrophic lateral sclerosis. In: Rowland LP, editor. Amyotrophic lateral sclerosis and other motor neuron diseases. Volume 56. New York: Raven Press. p 91-101.
28. Hirano A, Kurland LT, Sayre GP. 1967. Familial amyotrophic lateral sclerosis. Arch Neurol 16:232-243.
29. Ho BK, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH. 1996. Expression of calbindin-D28k in motoneuron hybrid cells after retroviral infection with calbindin-D28k cDNA prevents amyotrophic lateral sclerosis IgG-mediated toxicity. Proc Natl Acad Sci USA 93:6796-6801.
30. Hof PR, Morrison JH. 1999. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer disease. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins. p 207-232.
31. Hof PR, Bouras C, Morrison JH. 1999. Cortical neuropathology in aging and dementing disorders: neuronal typology, connectivity, and selective vulnerability. In: Peters A, Morrison JH, editors. Cerebral cortex. Volume 14, Neurodegenerative and age-related changes in cerebral cortex. New York: Kluwer Academic-Plenum. p 175-312.
32. Hollmann M, Heinemann SF. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
33. Howard CV, Reed MG. 1998. Unbiased stereology - three-dimensional measurement in microscopy. New York: Springer-Verlag.
34. Kiernan JA, Hudson AJ. 1991. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 114:843-853.
35. Kong J, Xu Z. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD-1. J Neurosci 18:3241-3250.
36. Kunst CB, Mezey E, Brownstein MJ, Patterson D. 1997. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 15:91-94.
37. Leigh PN, Swash M. 1991. Cytoskeletal pathology in motor neuron disease. In: Rowland LP, editor. Amyotrophic lateral sclerosis and other motor neuron diseases. Volume 56. New York: Raven Press. p 115-124.
38. Leveille A, Kiernan J, Goodwin JA, Antel J. 1982. Eye movements in amyotrophic lateral sclerosis. Arch Neurol 39:684-686.
39. Lipps MB, Keller BU. 1998. Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouse. J Physiol 511:105-117.
40. Lledo PM, Somasundaram B, Morton AJ, Emson PC, Mason WT. 1992. Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron 9:943-954.
41. Marti-Fabregas J, Roig C. 1993. Oculomotor abnormalities in motor neuron disease. J Neurol 240:475-478.
42. Mattson MP, Rychlik B, Chu C, Christakos S. 1991. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6:41-51.
43. Medina L, Figueredo-Cardenas G, Rothstein JD, Reiner A. 1996. Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups. Exp Neurol 142:287-295.
44. Morrison BM, Morrison JH. 1999. Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration. Brain Res Rev 29:121-135.
45. Morrison BM, Gordon JW, Ripps ME, Morrison JH. 1996. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J Comp Neurol 373:619-631.
46. Morrison BM, Janssen WG, Gordon JW, Morrison JH. 1998a. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J Comp Neurol 391:64-77.
47. Morrison BM, Janssen WGM, Gordon JW, Morrison JH. 1998b. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J Comp Neurol 395:523-534.
48. Morrison BM, Morrison JH, Gordon JW. 1998c. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis. J Exp Zool 282:32-47.
49. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC. 1996. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 93:5472-5477.
50. Nimchinsky EA, Hof PR, Shah RA, Yeung G, Young WG, Bloom FE, Morrison JH. 1998. Stereologic analysis of braintem motor nuclei in an SOD1 mutant mouse model of amyotrophic lateral sclerosis. Soc Neurosci Abstr 24:1203.
51. Nishida CR, Gralla EB, Valentine JS. 1994. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 91:9906-9910.
52. Okamoto K, Hirai S, Amari M, Iizuka T, Watanabe M, Murakami N, Takatama M. 1993. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol 85:458-462.
53. 2+ channels in motoneurons of the rat facial nucleus. J Neurosci 18:9573-9584.
54. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47.
55. Reiner A, Medina L, Figueredo-Cardenas G, Anfinson S. 1995. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanisms in sporadic ALS. Exp Neurol 131:239-250.
56. Ren K, Ruda MA. 1994. A comparative study of the calcium-binding proteins calbindin-D28k, calretinin, calmodulin and parvalbumin in the rat spinal cord. Brain Res Rev 19:263-179.
57. Résibois A, Rogers JH. 1992. Calretinin in rat brain: an immunohistochemical study. Neuroscience 46:101-134.
58. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. 1995. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92:689-693.
59. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown Jr RH. 1993. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
60. Rothstein JD, Van Kammen M, Levey AI, Martin L, Kunel RW. 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
61. Rowland LP. 1994. Natural history and clinical features of amyotrophic lateral sclerosis and related motor neuron diseases. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: W.B. Saunders. p 507-521.
62. Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. 1998. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci 18:9673-9684.
63. Schmitz C, Schuster D, Niessen P, Korr H. 1999. No difference between estimated mean nuclear volumes of various types of neurons in the mouse brain obtained on either isotropic uniform random sections or conventional frontal or sagittal sections. J Neurosci Methods 88:71-82.
64. Shaw PJ, Williams TL, Slade JY, Eggett CJ, Ince PG. 1999. Low expression of GluR2 AMPA receptor subunit potein by human motor neurons. NeuroReport 10:261-265.
65. Sidman RL, Angevine JB, Taber Pierce E. 1971. Atlas of the mouse brain and spinal cord. Cambridge: Harvard University Press.
66. Siklós L, Engelhardt JI, Alexianu ME, Gurney ME, Siddique T, Appel SH. 1998. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J Neuropathol Exp Neurol 57:571-587.
67. Tandan R. 1994. Clinical features and differential diagnosis of classical motor neuron disease. In: Williams AC, editor. Motor neuron disease. London: Chapman and Hall. p 3-28.
68. Tsuda T, Munthasser S, Fraser PE, Percy ME, Rainero I, Vaula G, Pinessi L, Bergamini L, Vignocchi G, Crapper McLachlan DR, Tatton WG, St George-Hyslop P. 1994. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 13:727-736.
69. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VMY. 1996. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160.
70. Uemura-Sumi M, Itoh M, Mizuno N. 1988. The distribution of hypoglossal motoneurons in the dog, rabbit and rat. Anat Embryol 177:389-394.
71. Vedel-Jensen EB, Gundersen HJG. 1993. The rotator. J Microsc 170:35-44.
72. West MJ, Slomianka L, Gundersen HJG. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
73. West MJ, Østergaard K, Andreasen OA, Finsen B. 1996. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 370:11-22.
74. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE. 1996. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271:515-518.
75. Williamson TL, Cleveland DW. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2:50-56.
76. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
77. m for hydrogen peroxide. Proc Natl Acad Sci USA 93:5709-5714.
78. Young WG, Nimchinsky EA, Hof PR, Morrison JH, Bloom FE. 1997. NeuroZoom software user guide and reference books. San Diego: YBM Software Associates Inc. 1038 p. [CD-ROM available from http:// neurozoom-scripps.edu]
79. Zhang B, Tu PH, Abtahian F, Trojanowski JQ, Lee VMY. 1997. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 139:1307-1315.